Following a judge’s ruling that suspended most of the Trump administration’s appointments to the CDC’s vaccine advisory panel, a newly published charter for the panel

The price differential between the US and other countries “will be significantly narrower or smaller” going forward because of pressure from the Trump administration’s “most

The FDA has once again rejected Replimune’s oncolytic virus therapy to treat advanced melanoma. The Massachusetts-based drugmaker had been pushing for a reconsideration by the

Five people with beta thalassemia who had their blood stem cells genetically altered no longer require regular blood transfusions to stay healthy. Their Chinese-made treatment

New China-US biotech gets $54M: Vivatides Therapeutics raised the Series A for its preclinical-stage R&D in siRNA and antisense oligonucleotides aimed at reaching tissues beyond